Tag: digital health

In a significant move that signals a definitive shift in corporate strategy and leadership, STAAR Surgical Company has announced the appointment of David Bailey as its new Chief Commercial Officer. This appointment marks a high-profile return for Bailey, who previously served as the company’s Chief Executive Officer and was a central figure in the shareholder-led…

Stryker Corporation, a global leader in medical technology, is navigating a complex landscape of manufacturing bottlenecks and shifting consumer behavior as it moves through the second half of the 2026 fiscal year. Speaking at a major healthcare investor conference on September 10, 2026, Stryker Chief Financial Officer Preston Wells provided a candid assessment of the…

The global medical technology landscape is currently witnessing a transformative shift in the treatment of cardiac arrhythmias, led by significant advancements in ablation technology. Abbott Laboratories, a titan in the cardiovascular device sector, has recently accelerated its efforts to dominate the electrophysiology market with the introduction and pending rollout of two pivotal technologies: the TactiFlex…

The global diagnostic and drug development landscape shifted significantly this quarter as Labcorp, a titan in the laboratory services sector, announced the successful acquisition of MLM Medical Labs. This strategic move effectively integrates MLM’s specialized laboratory network into Labcorp’s sprawling biopharma laboratory services division, creating a wholly owned, unified infrastructure that spans North America, Europe,…

The Food and Drug Administration (FDA) is embarking on a pivotal journey to regulate the integration of generative artificial intelligence (GenAI) into medical devices, marking a significant shift in how the agency oversees high-stakes digital health technology. Following years of internal debate and the rapid proliferation of consumer-facing tools like ChatGPT and Claude, the FDA’s…

Boston-based medical technology innovator Elucid has announced a significant expansion of its commercial operations and clinical development pipeline, bolstered by a fresh influx of capital and a strategic partnership with a major, undisclosed medtech leader. This development comes as the company seeks to redefine the standard of care for cardiovascular diagnostics through its proprietary artificial…

Boston Scientific Corporation disclosed on Tuesday that a significant cyberattack recently targeting its internal systems is expected to negatively impact its financial performance for both the third quarter and the full fiscal year of 2026. In a formal filing with the Securities and Exchange Commission (SEC), the Massachusetts-based medical technology giant admitted that it is…

In a significant advancement for the integration of artificial intelligence within clinical diagnostics, the Berlin-based health technology firm Vara has officially received a CE mark under the European Union’s Medical Device Regulation (MDR) for its autonomous breast cancer screening triage feature. This regulatory milestone permits the company’s AI platform to independently identify and report mammograms…

Boston Scientific has officially commenced the restoration of its global shipping operations approximately one week after a sophisticated cyberattack paralyzed the medical technology giant’s manufacturing and distribution networks. In a comprehensive update released Thursday, the Marlborough, Massachusetts-based company confirmed that shipping capabilities have been reinstated for the majority of its product portfolio at primary distribution…

The U.S. Food and Drug Administration (FDA) has designated a recent recall of Boston Scientific’s Infinion CX surgical leads as Class I, the most serious category of recall, reserved for situations where there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.…